Prolonged intake of desloratadine: mesenteric lymphatic vessel dysfunction and development of obesity/metabolic syndrome
Authors:
- 1 January 2019
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 316 (1) , G217-G227
Abstract
This study aimed to establish mechanistic links between the prolonged intake of desloratadine, a common H1 receptor blocker (i.e., antihistamine), and development of obesity and metabolic syndrome. Male Sprague-Dawley rats were treated for 16 wk with desloratadine. We analyzed the dynamics of body weight gain, tissue fat accumulation/density, contractility of isolated mesenteric lymphatic vessels, and levels of blood lipids, glucose, and insulin, together with parameters of liver function. Prolonged intake of desloratadine induced development of an obesity-like phenotype and signs of metabolic syndrome. These alterations in the body included excessive weight gain, increased density of abdominal subcutaneous fat and intracapsular brown fat, high blood triglycerides with an indication of their rerouting toward portal blood, high HDL, high fasting blood glucose with normal fasting and nonfasting insulin levels (insulin resistance), high liver/body weight ratio, and liver steatosis (fatty liver). These changes were associated with dysfunction of mesenteric lymphatic vessels, specifically high lymphatic tone and resistance to flow together with diminished tonic and abolished phasic responses to increases in flow, (i.e., greatly diminished adaptive reserves to respond to postprandial increases in lymph flow). The role of nitric oxide in this flow-dependent adaptation was abolished, with remnants of these responses controlled by lymphatic vessel-derived histamine. Our current data, considered together with reports in the literature, support the notion that millions of the United States population are highly likely affected by underevaluated, lymphatic-related side effects of antihistamines and may develop obesity and metabolic syndrome due to the prolonged intake of this medication. NEW & NOTEWORTHY Prolonged intake of desloratadine induced development of obesity and metabolic syndrome associated with dysfunction of mesenteric lymphatic vessels, high lymphatic tone, and resistance to flow together with greatly diminished adaptive reserves to respond to postprandial increases in lymph flow. Data support the notion that millions of the USA population are highly likely affected by underevaluated, lymphatic-related side effects of antihistamines and may develop obesity and metabolic syndrome due to the prolonged intake of this medication.Keywords
Funding Information
- NIH (DK099161, HL123420, DK108959, AG030578)
- VA (1I01BX003031)
- NSF (DBI-1455671)
- DOD (FA9550-15-1-0517, FA9550-18- 1-0141)
- CPRIT (RP160834)
This publication has 46 references indexed in Scilit:
- Activation of rat intestinal mucosal mast cells by fat absorptionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Impairments in the intrinsic contractility of mesenteric collecting lymphatics in a rat model of metabolic syndromeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Mesenteric lymph flow in adult and aged ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination SurveyObesity, 2010
- Effect of histamine on spontaneous contractions of mesenteric lymphatic vessels and lymph nodes of white rats: Endothelium-dependent responsesDoklady Biological Sciences, 2010
- Phasic contractions of rat mesenteric lymphatics increase basal and phasic nitric oxide generation in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Methods for Lymphatic Vessel Culture and Gene TransfectionMicrocirculation, 2009
- The Obesity Epidemic in the United States Gender, Age, Socioeconomic, Racial/Ethnic, and Geographic Characteristics: A Systematic Review and Meta-Regression AnalysisEpidemiologic Reviews, 2007
- Contraction‐initiated NO‐dependent lymphatic relaxation: a self‐regulatory mechanism in rat thoracic ductThe Journal of Physiology, 2006
- The toxicity of dimethyl sulphoxide (DMSO) for the dog, pig, rat and rabbitToxicology, 1975